All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @heidisomers on TikTok · 40s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @heidisomers's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00I am on a break from IVF right now and we are doing testosterone priming is what it's called.
  2. 0:05I basically put testosterone gel on my arms every evening and we're priming to get ready for cycle
  3. 0:11number Cinco. So that is what we're doing right now. I was like all excited. I'm like I'm doing this
  4. 0:1621-day challenge and they're like okay like you might gain weight. I might get a deeper voice.
  5. 0:20Few things might change. I'm a little bit nervous but it's not like a lot of guys they inject themselves
  6. 0:25of testosterone and it skyrockets the gel is so barely there with testosterone but they were like
  7. 0:30you might see a few things so I keep going over to Christian and I'm like with that is the plan
  8. 0:34right now we're doing testosterone priming. We're trying to do different little things with each IVF cycle.

Heidi Somers's IVF journey claims need medical context

Heidi Somers | Buffbunny

TikTok creator

40.7K viewsWatch on TikTok

Quick answer

Transdermal testosterone priming before controlled ovarian hyperstimulation is an emerging but evidence-supported protocol primarily studied in poor ovarian responders, a population to which Heidi likely belongs given five IVF cycles. The gel-based approach produces low physiologic androgen levels intended to upregulate FSH receptor expression in early follicles, not to achieve the supraphysiologic testosterone levels associated with male TRT. Clinical use requires a prescription and monitoring from a reproductive endocrinologist, as dosing and timing are individualized.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Heidi Somers's IVF journey claims need medical context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Heidi Somers's IVF journey claims need medical context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Heidi Somers's IVF journey claims need medical context" from Heidi Somers | Buffbunny. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Transdermal testosterone priming before controlled ovarian hyperstimulation is an emerging but evidence-supported protocol primarily studied in poor ovarian responders, a population to which Heidi likely belongs given five IVF cycles.

The reason this review is not generic is the source wording and the canonical claim label "trt cycle 5 here we go again some days this journey feels heav." In this clip, the useful excerpt is: "I am on a break from IVF right now and we are doing testosterone priming is what it's called." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

IVF priming doses of testosterone gel, typically 5-10mg daily, are designed to produce low physiologic androgen levels, not the supraphysiologic levels seen in male TRT, making serious androgenic side effects unlikely but not impossible.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Transdermal testosterone priming before controlled ovarian hyperstimulation is an emerging but evidence-supported protocol primarily studied in poor ovarian responders, a population to which Heidi likely belongs given five IVF cycles.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Transdermal testosterone priming before controlled ovarian hyperstimulation is an emerging but evidence-supported protocol primarily studied in poor ovarian responders, a population to which Heidi likely belongs given five IVF cycles. The gel-based approach produces low physiologic androgen levels intended to upregulate FSH receptor expression in early follicles, not to achieve the supraphysiologic testosterone levels associated with male TRT. Clinical use requires a prescription and monitoring from a reproductive endocrinologist, as dosing and timing are individualized.
  • A 2019 meta-analysis by Noventa et al. in Reproductive BioMedicine Online found transdermal testosterone priming was associated with higher clinical pregnancy and live birth rates in poor ovarian responders undergoing IVF.
  • IVF priming doses of testosterone gel, typically 5-10mg daily, are designed to produce low physiologic androgen levels, not the supraphysiologic levels seen in male TRT, making serious androgenic side effects unlikely but not impossible.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • A 2019 meta-analysis by Noventa et al. in Reproductive BioMedicine Online found transdermal testosterone priming was associated with higher clinical pregnancy and live birth rates in poor ovarian responders undergoing IVF.
  • IVF priming doses of testosterone gel, typically 5-10mg daily, are designed to produce low physiologic androgen levels, not the supraphysiologic levels seen in male TRT, making serious androgenic side effects unlikely but not impossible.
  • Testosterone acts on FSH receptors in granulosa cells and early follicles, giving the priming strategy a biologically plausible mechanism rather than just clinical guesswork.
  • Skin transfer is a real safety consideration with testosterone gel. Users should let the gel dry fully and wash hands before contact with partners or children.
  • The Poseidon classification system (Esteves et al., Frontiers in Endocrinology, 2016) stratifies poor-prognosis IVF patients and can help clinicians identify who is most likely to benefit from protocols like testosterone priming.
  • Testosterone priming and DHEA supplementation are both androgen-based strategies used in IVF but are pharmacologically distinct and should not be conflated or self-administered.
  • This is a prescription protocol requiring direct clinical supervision. Seeing it discussed on social media, even accurately, is not a substitute for evaluation by a reproductive endocrinologist.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @heidisomers actually say?

On her fifth IVF cycle, Heidi is using transdermal testosterone gel applied to her arms each evening, a protocol her clinic described as "testosterone priming." She's doing a 21-day course before her next retrieval cycle. She acknowledged potential side effects, including weight changes and voice deepening, but reasonably noted that the gel delivers far less testosterone than injected protocols used by men on TRT. She's being transparent about the process, which is refreshing.

What she described is a real, evidence-supported protocol used in some reproductive medicine clinics to improve ovarian response before IVF, particularly in women who have responded poorly to standard stimulation. This is not fringe medicine. It is not something she invented. Her clinic prescribed it, and there is actual published data behind it.

Does the science back this up?

Yes, more than most people realize. Testosterone priming before ovarian stimulation has a legitimate evidence base, though researchers are still working out who benefits most and what the optimal protocol looks like.

The rationale is biological: androgen receptors are present in granulosa cells and early follicles. Testosterone appears to upregulate FSH receptors and promote follicle growth in the preantral and antral stages. A 2019 meta-analysis by Noventa et al. in Reproductive BioMedicine Online found that transdermal testosterone supplementation was associated with significantly higher clinical pregnancy rates and live birth rates in poor ovarian responders undergoing IVF. A separate randomized controlled trial by Balasch et al., published in Human Reproduction, also supported improved follicle yield in low-responder patients. The effect is not massive, but for women who have already failed multiple cycles, modest gains matter. Heidi is on her fifth cycle, which puts her squarely in the population where this protocol has shown the most promise.

What did they get wrong (or right)?

Heidi got the pharmacology broadly right. Her description of the gel as delivering a much lower testosterone load than injectable TRT used by men is accurate. Transdermal testosterone absorbs at roughly 10 percent efficiency, and the doses used in IVF priming protocols, typically 5-10mg daily, are designed to achieve low physiologic levels, not the supraphysiologic ranges associated with masculinizing effects.

That said, her framing of side effects as unlikely could be slightly understated. Voice changes are genuinely rare at these doses and duration, but mild androgenic effects like acne, increased libido, or mood shifts are not uncommon even at low doses in some women. These are reversible. The more important thing she did not mention is absorption transfer risk. Transdermal gels can transfer to partners or children through skin contact, and that is something anyone using these products should know. Her clinic likely told her, but it did not make the video.

What should you actually know?

If you are a poor ovarian responder considering IVF, testosterone priming is worth a direct conversation with your reproductive endocrinologist. It is not a guaranteed fix, and the evidence is stronger for some subgroups than others. The Poseidon classification, a stratification system for poor prognosis IVF patients developed by a group of European reproductive specialists and published in Frontiers in Endocrinology in 2016, helps clinicians identify who is most likely to respond.

A few practical points worth knowing:

  • Priming duration in published studies ranges from 5 to 21 days before stimulation starts. The 21-day protocol Heidi mentioned is on the longer end but within the studied range.
  • Testosterone priming is distinct from DHEA supplementation, which is another androgen strategy some clinics use. They are not interchangeable.
  • Side effects at these doses are typically mild and reversible after stopping the gel.
  • Transfer precautions matter. Wash hands after application and allow the gel to dry before skin-to-skin contact.
  • This is a prescription protocol requiring clinical oversight. Do not self-administer testosterone based on content you see online.

Heidi is doing this under clinical supervision, which is exactly how it should be done. Her transparency about being on her fifth cycle, and still showing up, is worth acknowledging.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Heidi Somers | Buffbunny · TikTok creator

40.7K views on this video

Cycle 5. Here we go again. Some days this journey feels heavy but I’m not giving up on this dream. If you're in a season of patience + persistence too… I’m right here with you 🤍 Full video link in bi

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about a 2019 meta-analysis by noventa et al. in reproductive biomedicine?

A 2019 meta-analysis by Noventa et al. in Reproductive BioMedicine Online found transdermal testosterone priming was associated with higher clinical pregnancy and live birth rates in poor ovarian responders undergoing IVF.

What does the video say about ivf priming doses of testosterone gel, typically 5-10mg daily,?

IVF priming doses of testosterone gel, typically 5-10mg daily, are designed to produce low physiologic androgen levels, not the supraphysiologic levels seen in male TRT, making serious androgenic side effects unlikely but not impossible.

What does the video say about testosterone acts on fsh receptors in granulosa cells?

Testosterone acts on FSH receptors in granulosa cells and early follicles, giving the priming strategy a biologically plausible mechanism rather than just clinical guesswork.

What does the video say about skin transfer?

Skin transfer is a real safety consideration with testosterone gel. Users should let the gel dry fully and wash hands before contact with partners or children.

What does the video say about the poseidon classification system (esteves et al., frontiers in endocrinology,?

The Poseidon classification system (Esteves et al., Frontiers in Endocrinology, 2016) stratifies poor-prognosis IVF patients and can help clinicians identify who is most likely to benefit from protocols like testosterone priming.

What does the video say about testosterone priming?

Testosterone priming and DHEA supplementation are both androgen-based strategies used in IVF but are pharmacologically distinct and should not be conflated or self-administered.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Heidi Somers | Buffbunny, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.